Anokion SA   Report issue

For profit Phase 1
Founded: Ecublens Switzerland (2010)

Organization Overview

First Clinical Trial
2020
NCT04602390
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Anokion SA